After 10 months this is all they have to say ??
• Starpharma continues to progress with a dual strategy to achieve US approval for VivaGel® BV with input from its team of expert FDA consultants, statisticians and legal advisors. In parallel with seeking further review of some of the FDA’s initial conclusions, Starpharma has also undertaken significant preparations for a possible BV treatment trial, if required.
If you were confident you wouldn't undertake "significant preparations" that would cost money IMO - just sayin'
Vote no IMO for remuneration !!
Nothing exciting in the announcement at all IMO
Ann: Quarterly Cashflow Report, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |